The level of thyroid-stimulating hormone (TSH)-stimulated thyroglobulin (Tg) after thyroid hormone withdrawal (THW) is the most sensitive marker for detecting recurrence of differentiated thyroid cancer (DTC). In DTC, Tg production is regulated by TSH; however, TSH values after THW are never identical, even in the same patient. The objective of this study was to evaluate the influence of TSH on Tg levels after THW. Materials and Methods: TSH and Tg concentrations were measured twice at 2 and 3 weeks after THW in 309 patients with DTC. TSH and Tg levels at these time points were compared. The percent change in TSH (ΔTSH) and change in Tg level (%ΔTg) from 2 to 3 weeks after THW were calculated, and Pearson's correlation coefficients were calculated to determine whether ΔTSH could affect %ΔTg. Tg cutoff value for diagnostic imaging was 2 ng/mL. Results: The TSH and Tg values at 3 weeks were significantly higher than those at 2 weeks after THW. Tg values increased significantly to ＞2 ng/mL after 1 week in 38.5% of the patients with Tg values of 0.2-2 ng/mL at 2 weeks after THW. In patients with Tg values ≥2 ng/mL at 2 weeks after THW, Tg values increased significantly after an additional week of THW. ΔTSH correlated significantly with %ΔTg. Conclusion: TSH values differed according to time after THW, and Tg values differed significantly according to TSH values. Therefore, TSH values should be considered carefully when interpreting the meaning of Tg levels in patients with DTC. and neck ultrasound), and undetectable serum thyroglobulin (Tg) values during thyroid-stimulating hor-
Introduction
Differentiated thyroid carcinoma (DTC), the most common type of endocrine malignancy, has an excellent prognosis and 10-year survival rate higher than 90%. 1, 2) This outcome has been ensured by increased diagnostic scrutiny. However, the DTC recurrence rate is 10-30%, and the potential for reappearance after several years 3, 4) indicates the need for prolonged follow-up.
According to the American Thyroid Association guideline, 5) a disease-free status comprises all of the following: no clinical evidence of tumor, no imaging evidence of tumor (i.e., no uptake outside the thyroid bed on the initial post-treatment whole-body scan or, if uptake outside the thyroid bed is present, no imaging evidence of tumor on a recent diagnostic scan The TSH-stimulated Tg level after successful thyroid ablation is known as a sensitive and reliable marker for surveilling tumor persistence and recurrence, 6, 7) particularly in patients with low or undetectable Tg values in the absence of TSH stimulation. Frequently, stimulated Tg cutoff values of ＞1-2.5 ng/mL are used to detect or predict persistent disease. [8] [9] [10] [11] [12] 
Materials and Methods

Statistical Analysis
For analysis, patients were divided into three groups according to their Tg values at 2 weeks after THW ( Fig. 2 standard deviations (SDs). A p value ＜0.05 was considered to indicate a statistically significant difference.
Results
Patient Characteristics
The characteristics of all 309 patients are presented in Changes in TSH and Tg Values between 2 and 3 Weeks after THW Fig. 3 and Supplementary Fig. 1 crease in Tg after the additional week of THW (Table 2) .
In a final group of 53 patients with Tg values ≥2 ng/mL, the Tg values of all but one patient remained in the same Tg category (≥2 ng/mL) after an additional week of THW (Fig. 4) , and all but one of the 52 patients exhibited increased Tg values after the additional week (Table 3) .
To evaluate the correlation between the changes in TSH and Tg values, we subjected 190 patients with detectable Tg values in both the first and second tests to a linear regression analysis and Pearson's correlation analysis. The %ΔTg was found to correlate positively with the ΔTSH (p=0.0001), with a correlation coefficient of 0.2881. We also performed the same analysis in the 53 patients with Tg values ≥2 ng/mL at 2 weeks after THW, a value that is suggestive of tum or recurrence or persistent tum or burden. The % ΔTg was also found to correlate positively with the ΔTSH (p=0.0001), with a correlation coefficient of 0.5037 (Fig. 5 ).
We performed a sub-analysis of 22 
Discussion
Generally, serum Tg values are used to predict successful thyroid remnant ablation, 19) assess responses to RAI therapy, 20) detect recurrent tumors, 6, 21) and predict disease recurrence 22, 23) and prognosis. 24, 25) A few studies have demonstrated that Tg values could increase in accordance with increases in TSH values.
18)
The current large-scale study aimed to determine Meanwhile, the current study was limited by a THW duration of only 3 weeks. It remains unknown how long the TSH and Tg would continue to increase.
Although they used a different THW protocol, Valle et al. 18) reported that 4 weeks of THW was not sufficient to reach a final Tg value. The mean TSH values of the current study were lower than the range of 80-100 μU/mL suggested by their study. Nevertheless, in actual clinical situations, 3-4 weeks is a common interval for levothyroxine withdrawal. If levothyroxine is withdrawn for ≥4 weeks, liothyronine may be substituted; in such circumstances, 2-3 weeks is a common time period for liothyronine withdrawal. The current study did not assess the clinical significance of an increase in Tg values to ＞2 ng/mL at 3 weeks after THW. In future studies, we will investigate the clinical significance of a Tg increase after an additional week of THW.
In conclusion, the Tg value increases significantly in accordance with the increase in TSH values in patients with initially detectable Tg values. Careful consideration should be given to the TSH value when in-terpreting the meaning of changes in Tg levels in patients with DTC, as TSH values can always vary, even within the same patient and when the values exceed the cutoff (30 μU/mL), and can affect every measurement of stimulated Tg.
